Amir Emami

21.1k total citations · 1 hit paper
96 papers, 2.1k citations indexed

About

Amir Emami is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Amir Emami has authored 96 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 30 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Amir Emami's work include COVID-19 Clinical Research Studies (15 papers), Antibiotic Resistance in Bacteria (12 papers) and Bacterial biofilms and quorum sensing (11 papers). Amir Emami is often cited by papers focused on COVID-19 Clinical Research Studies (15 papers), Antibiotic Resistance in Bacteria (12 papers) and Bacterial biofilms and quorum sensing (11 papers). Amir Emami collaborates with scholars based in Iran, United States and Germany. Amir Emami's co-authors include Fatemeh Javanmardi, Ali Akbari, Neda Pirbonyeh, Abdolkhalegh Keshavarzi, Ali A. Asadi‐Pooya, Mehrzad Lotfi, Afagh Moattari, Hamid Nemati, Wolfram Doehner and Anja Sandek and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Biological Macromolecules.

In The Last Decade

Amir Emami

94 papers receiving 2.1k citations

Hit Papers

Prevalence of Underlying Diseases in Hospitalized Patient... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Emami Iran 21 790 646 319 262 261 96 2.1k
Yitshak Kreiss Israel 26 1.6k 2.0× 276 0.4× 426 1.3× 158 0.6× 151 0.6× 82 3.1k
Louise Sigfrid United Kingdom 21 775 1.0× 891 1.4× 422 1.3× 306 1.2× 98 0.4× 52 1.9k
Michael Rubin United States 30 755 1.0× 271 0.4× 164 0.5× 695 2.7× 50 0.2× 139 2.9k
Eli Harriss United Kingdom 20 372 0.5× 530 0.8× 452 1.4× 144 0.5× 153 0.6× 81 2.1k
Min Seo Kim South Korea 25 238 0.3× 139 0.2× 135 0.4× 244 0.9× 109 0.4× 121 2.1k
Paulina A. Rebolledo United States 15 1.0k 1.3× 1.8k 2.8× 928 2.9× 162 0.6× 93 0.4× 54 2.7k
Douglas J. Passaro United States 19 251 0.3× 277 0.4× 117 0.4× 406 1.5× 194 0.7× 32 2.8k
Raghavendra Tirupathi United States 13 601 0.8× 507 0.8× 282 0.9× 122 0.5× 96 0.4× 43 1.3k
Ali Bijani Iran 27 202 0.3× 121 0.2× 169 0.5× 281 1.1× 176 0.7× 381 3.2k

Countries citing papers authored by Amir Emami

Since Specialization
Citations

This map shows the geographic impact of Amir Emami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Emami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Emami more than expected).

Fields of papers citing papers by Amir Emami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Emami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Emami. The network helps show where Amir Emami may publish in the future.

Co-authorship network of co-authors of Amir Emami

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Emami. A scholar is included among the top collaborators of Amir Emami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Emami. Amir Emami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Asvar, Zahra, Neda Pirbonyeh, Amir Emami, et al.. (2024). Enhancing antibacterial activity against multi-drug resistant wound bacteria: Incorporating multiple nanoparticles into chitosan-based nanofibrous dressings for effective wound regeneration. Journal of Drug Delivery Science and Technology. 95. 105542–105542. 10 indexed citations
3.
Zareshahrabadi, Zahra, et al.. (2022). COVID ‐19‐associated facial cutaneous mucormycosis superinfection: A potentially life‐threatening disease. SHILAP Revista de lepidopterología. 10(7). e6103–e6103. 3 indexed citations
4.
Emami, Amir, Ali Akbari, Fatemeh Javanmardi, et al.. (2021). Designing a Multicenter Registry of COVID-19 and Other Respiratory Infections in Fars, Iran. Disaster Medicine and Public Health Preparedness. 16(5). 1761–1764. 2 indexed citations
5.
Emami, Amir, et al.. (2021). The role of comorbidities on mortality of COVID-19 in patients with diabetes. Obesity Medicine. 25. 100352–100352. 16 indexed citations
6.
Asadi‐Pooya, Ali A., Hamid Nemati, Mina Shahisavandi, et al.. (2021). Long COVID in children and adolescents. World Journal of Pediatrics. 17(5). 495–499. 108 indexed citations
7.
Jahromi, Mohammad Ali Farboodniay, et al.. (2020). Antibacterial and Antioxidant Activity of extract and fractions of Lonicera nummularifolia Jaub & Spach. SHILAP Revista de lepidopterología.
8.
Khorram, Mohammad, et al.. (2020). Glucantime-loaded electrospun core-shell nanofibers composed of poly(ethylene oxide)/gelatin-poly(vinyl alcohol)/chitosan as dressing for cutaneous leishmaniasis. International Journal of Biological Macromolecules. 163. 288–297. 35 indexed citations
9.
Emami, Amir, et al.. (2020). <p>Three Year Study of Infection Profile and Antimicrobial Resistance Pattern from Burn Patients in Southwest Iran</p>. Infection and Drug Resistance. Volume 13. 1499–1506. 11 indexed citations
10.
Emami, Amir, Neda Pirbonyeh, Afagh Moattari, Abdollah Bazargani, & Mohammad Motamedifar. (2019). Risk of otitis media with effusion (OME) in children by Pseudomonas aeruginosa. International Journal of Pediatric Otorhinolaryngology. 125. 6–10. 5 indexed citations
11.
Emami, Amir, et al.. (2018). Bactericidal activity of pigments isolated from Fars province (Iran) environmental bacteria on MDR clinical isolates of Acinetobacter. 8(1). 922–930. 1 indexed citations
12.
Pirbonyeh, Neda, et al.. (2017). Cross Sectional Study of Burn Infections and Antibiotic Susceptibility Pattern for the Improvement of Treatment Policy. SHILAP Revista de lepidopterología. 4 indexed citations
13.
Emami, Amir, et al.. (2017). Emergence of S. Lugdunensis in Burn Wound Infection of Hospitalized Patients. 5(4). 616–620. 1 indexed citations
15.
Emami, Amir, Mohammad Reza Fattahi, Alireza Salehi, et al.. (2015). Assessment of the impacts of traditional Persian medical schemes and recommendations on functional chronic constipation compared to a classic medicine lactulose, a randomized clinical trial. Journal of Complementary and Integrative Medicine. 12(4). 325–331. 8 indexed citations
16.
Nia, Hamid Sharif, et al.. (2014). Clinical manifestations of myocardial infarction in diabetic and non-diabetic patients. 7(2). 116–123. 5 indexed citations
17.
Haghdoost, Ali Akbar, et al.. (2012). Cost Analysis for Cancer Subgroups in Kerman, IRAN. SHILAP Revista de lepidopterología. 8(1). 62–70. 2 indexed citations
18.
Moattari, Afagh, Amir Emami, Mohsen Moghadami, & Behnam Honarvar. (2012). Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran. Influenza and Other Respiratory Viruses. 6(6). e77–9. 42 indexed citations
19.
Moghadami, Mohsen, Behnam Honarvar, Mostafa Ebrahimi, et al.. (2010). Influenza A (H1N1) Virus Pandemic in Fars Province: A Report from Southern Iran, July-December 2009. Iranian Red Crescent Medical Journal. 12(3). 231–238. 8 indexed citations
20.
Emami, Amir, et al.. (2008). COLONIZATION RATE OF INTRAVASCULAR CATHETERS AND CATHETER RELATED BLOOD STREAM INFECTION IN NICU WARD OF NAMAZEE HOSPITAL, SHIRAZ, IRAN. Archives of Disease in Childhood. 93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026